Outpatient management of DVT using low molecular weight heparin and a hospital outreach service

Clinical and Laboratory Haematology

Volumn 24, Issue 3, 2002, Pages 165-170

  Rymes, N L ^a   Lester, W ^a   Connor, C ^a   Chakrabarti, S ^a   Fegan, C D ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Deep venous thrombosis; Hospital outreach; Low molecular weight heparin

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT; HEPARIN; WARFARIN;

ADULT; AGE; AGED; ARTICLE; BLEEDING; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG SAFETY; FEMALE; HOME CARE; HOSPITAL CARE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT; PATIENT ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; SEX; AMBULATORY CARE; CAUSE OF DEATH; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; HOSPITAL READMISSION; LENGTH OF STAY; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PUBLIC HOSPITAL; PUBLIC RELATIONS; RETROSPECTIVE STUDY; STANDARD; UNITED KINGDOM; UTILIZATION REVIEW; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTICOAGULANTS; CAUSE OF DEATH; COMMUNITY-INSTITUTIONAL RELATIONS; ENGLAND; FEMALE; HEMORRHAGE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HOSPITALS, PUBLIC; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT READMISSION; RECURRENCE; RETROSPECTIVE STUDIES; VENOUS THROMBOSIS; WARFARIN;

EID: 0036277839     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.2002.00440.x     Document Type: Article

References (12)

1. Flexible induction dose regimen for warfarin and prediction maintenance dose
2. Management of venous thromboembolism
3. Assessment of outpatient treatment of deep vein thrombosis with low molecular weight heparin
4. Low molecular weight heparin versus heparin in the treatment of patients with pulmonary embolism
5. Subcutaneous low molecular weight heparin compared with continuous intravenous heparin in the treatment of proximal vein thrombosis
6. Treatment of venous thrombosis with unfractionated heparin administered in the hospital as compared with subcutaneous low molecular weight heparin administered at home
7. Treatment of deep venous thrombosis with low molecular weight heparins: A meta-analysis
8. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
9. Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis: A feasibility and health economic study in an outpatient setting
10. Outpatient management of deep vein thrombosis
11. Nurse-led outpatient treatment of deep vein thrombosis
12. Comparison of subcutaneous low molecular weight heparin with intravenous standard heparin in proximal deep vein thrombosis